title: [Severe self-limiting hypersensitivity reaction after immunotherapy with intravesical BCG].
abstract: We present the case of a 67-years-old patient diagnosed of superficial vesical transitional carcinoma which, under immunotherapy with intravesical BCG, developed a severe hypersensitivity reaction with spontaneous resolution. We describe several adverse reactions after the administration of intravesical BCG, as well as its diagnostic and therapeutic problems, especially in the cases of hypersensitivity.
authors.affiliation: Unidad en Enfermedades Infecciosas, Hosital Universitario La Fe, Valencia.
authors.forename: F J
authors.initials: FJ
authors.lastname: Estelles Piera
authors.forename: A
authors.initials: A
authors.lastname: Campayo
authors.forename: J M
authors.initials: JM
authors.lastname: Valls Ferrer
authors.forename: J
authors.initials: J
authors.lastname: Lacruz
authors.forename: F M
authors.initials: FM
authors.lastname: Blanes Julia
authors.forename: J
authors.initials: J
authors.lastname: López Aldeguer
authors.forename: V
authors.initials: V
authors.lastname: Bonora Tamarit
mesh_terms: D000283:Administration, Intravesical; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D016233:Immunotherapy, Active / Q000009:adverse effects*; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D001500:BCG Vaccine
vernacular_title: Severa reacción de hipersensibilidad autolimitada tras inmunoterapia con BCG intravesical.